Who Owns NovoCure Stock?
NASDAQ: NVCRHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 90.23%
- Institutions (% of float)
- 100.14%
- Held by insiders
- 9.90%
- Institutional holders
- 343
- Institutions 90.1%
- Insiders 9.9%
- Public and other 0.0%
Who owns NovoCure stock?
Institutional investors own about 90.2% of NovoCure's shares, spread across 343 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 9.90% of NVCR.
The largest institutional holders are FMR, LLC (14.86%), Blackrock Inc. (10.15%) and Soleus Capital Management, L.P. (8.06%). Together, the top 10 institutions control 57.3% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their NVCR positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of NVCR
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 17.38M | 14.86% | +0.0% |
| Blackrock Inc. | 11.86M | 10.15% | -11.6% |
| Soleus Capital Management, L.P. | 9.43M | 8.06% | -4.9% |
| Vanguard Portfolio Management LLC | 6.49M | 5.55% | +3.5% |
| Vanguard Capital Management LLC | 4.92M | 4.21% | +0.4% |
| Morgan Stanley | 4.70M | 4.02% | +3.9% |
| Quantinno Capital Management, LP | 4.22M | 3.61% | +90.0% |
| State Street Corporation | 2.93M | 2.50% | +2.1% |
| Geode Capital Management, LLC | 2.81M | 2.40% | +0.3% |
| Wells Fargo & Company | 2.26M | 1.93% | -10.7% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of NVCR
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 5.87M | 5.02% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.49M | 2.99% |
| iShares Trust-iShares Russell 2000 ETF | 2.76M | 2.36% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.52M | 2.16% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund | 1.74M | 1.49% |
| Fidelity Mt. Vernon Street Trust-Fidelity Series Growth Company Fund | 1.55M | 1.33% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.45M | 1.24% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.21M | 1.04% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.17M | 1.00% |
| iShares Trust-iShares Russell 2000 Growth ETF | 930.43K | 0.80% |
Frequently asked questions
Who is the largest shareholder of NovoCure?
FMR, LLC is the largest institutional shareholder of NVCR, owning 14.86% of shares outstanding (17.38M shares) as of its latest 13F filing.
What percentage of NovoCure is owned by institutions?
Institutions own about 90.2% of NVCR shares and 100.1% of the public float.
How much of NovoCure do insiders own?
Insiders, such as officers and directors, own about 9.90% of NVCR shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.